These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37215142)

  • 1. The shed P2X7 receptor is an index of adverse clinical outcome in COVID-19 patients.
    Vultaggio-Poma V; Sanz JM; Amico A; Violi A; Ghisellini S; Pizzicotti S; Passaro A; Papi A; Libanore M; Di Virgilio F; Giuliani AL
    Front Immunol; 2023; 14():1182454. PubMed ID: 37215142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble P2X7 Receptor Is Elevated in the Plasma of COVID-19 Patients and Correlates With Disease Severity.
    García-Villalba J; Hurtado-Navarro L; Peñín-Franch A; Molina-López C; Martínez-Alarcón L; Angosto-Bazarra D; Baroja-Mazo A; Pelegrin P
    Front Immunol; 2022; 13():894470. PubMed ID: 35663992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection.
    Lécuyer D; Nardacci R; Tannous D; Gutierrez-Mateyron E; Deva Nathan A; Subra F; Di Primio C; Quaranta P; Petit V; Richetta C; Mostefa-Kara A; Del Nonno F; Falasca L; Marlin R; Maisonnasse P; Delahousse J; Pascaud J; Deprez E; Naigeon M; Chaput N; Paci A; Saada V; Ghez D; Mariette X; Costa M; Pistello M; Allouch A; Delelis O; Piacentini M; Le Grand R; Perfettini JL
    Front Immunol; 2023; 14():1270081. PubMed ID: 37920468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P2X7 receptor antagonism prevents IL-1β release from salivary epithelial cells and reduces inflammation in a mouse model of autoimmune exocrinopathy.
    Khalafalla MG; Woods LT; Camden JM; Khan AA; Limesand KH; Petris MJ; Erb L; Weisman GA
    J Biol Chem; 2017 Oct; 292(40):16626-16637. PubMed ID: 28798231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential involvement of P2X7 receptor in COVID-19 pathogenesis: A new therapeutic target?
    Pacheco PAF; Faria RX
    Scand J Immunol; 2021 Feb; 93(2):e12960. PubMed ID: 32797724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of hepatic stellate cell activation by extracellular ATP is dependent on P2X7R-mediated NLRP3 inflammasome activation.
    Jiang S; Zhang Y; Zheng JH; Li X; Yao YL; Wu YL; Song SZ; Sun P; Nan JX; Lian LH
    Pharmacol Res; 2017 Mar; 117():82-93. PubMed ID: 27940204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The P2X7 Receptor Is Shed Into Circulation: Correlation With C-Reactive Protein Levels.
    Giuliani AL; Berchan M; Sanz JM; Passaro A; Pizzicotti S; Vultaggio-Poma V; Sarti AC; Di Virgilio F
    Front Immunol; 2019; 10():793. PubMed ID: 31031771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P2X7 Receptor-Induced Bone Cancer Pain by Regulating Microglial Activity via NLRP3/IL-1beta Signaling.
    Wu P; Wu X; Zhou G; Wang Y; Liu X; Lv R; Liu Y; Wen Q
    Pain Physician; 2022 Nov; 25(8):E1199-E1210. PubMed ID: 36375190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The P2X7 receptor-NLRP3 inflammasome complex predicts the development of non-Hodgkin's lymphoma in Sjogren's syndrome: a prospective, observational, single-centre study.
    Baldini C; Santini E; Rossi C; Donati V; Solini A
    J Intern Med; 2017 Aug; 282(2):175-186. PubMed ID: 28503820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The P2X7R-NLRP3 and AIM2 Inflammasome Platforms Mark the Complexity/Severity of Viral or Metabolic Liver Damage.
    Rossi C; Salvati A; Distaso M; Campani D; Raggi F; Biancalana E; Tricò D; Brunetto MR; Solini A
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychological Stress Activates the Inflammasome via Release of Adenosine Triphosphate and Stimulation of the Purinergic Type 2X7 Receptor.
    Iwata M; Ota KT; Li XY; Sakaue F; Li N; Dutheil S; Banasr M; Duric V; Yamanashi T; Kaneko K; Rasmussen K; Glasebrook A; Koester A; Song D; Jones KA; Zorn S; Smagin G; Duman RS
    Biol Psychiatry; 2016 Jul; 80(1):12-22. PubMed ID: 26831917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trikafta Rescues CFTR and Lowers Monocyte P2X7R-induced Inflammasome Activation in Cystic Fibrosis.
    Gabillard-Lefort C; Casey M; Glasgow AMA; Boland F; Kerr O; Marron E; Lyons AM; Gunaratnam C; McElvaney NG; Reeves EP
    Am J Respir Crit Care Med; 2022 Apr; 205(7):783-794. PubMed ID: 35021019
    [No Abstract]   [Full Text] [Related]  

  • 13. Activated human CD4+CD45RO+ memory T-cells indirectly inhibit NLRP3 inflammasome activation through downregulation of P2X7R signalling.
    Beynon V; Quintana FJ; Weiner HL
    PLoS One; 2012; 7(6):e39576. PubMed ID: 22768094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The level of physical training modulates cytokine levels through P2X7 receptor in healthy subjects.
    Comassi M; Santini E; Rossi C; Vitolo E; Seghieri M; Tocchini L; Franzoni F; Solini A
    Eur J Clin Invest; 2018 Feb; 48(2):. PubMed ID: 29272042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P2X7R blockade prevents NLRP3 inflammasome activation and brain injury in a rat model of intracerebral hemorrhage: involvement of peroxynitrite.
    Feng L; Chen Y; Ding R; Fu Z; Yang S; Deng X; Zeng J
    J Neuroinflammation; 2015 Oct; 12():190. PubMed ID: 26475134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications.
    Potere N; Del Buono MG; Caricchio R; Cremer PC; Vecchié A; Porreca E; Dalla Gasperina D; Dentali F; Abbate A; Bonaventura A
    EBioMedicine; 2022 Nov; 85():104299. PubMed ID: 36209522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients.
    Rodrigues TS; de Sá KSG; Ishimoto AY; Becerra A; Oliveira S; Almeida L; Gonçalves AV; Perucello DB; Andrade WA; Castro R; Veras FP; Toller-Kawahisa JE; Nascimento DC; de Lima MHF; Silva CMS; Caetite DB; Martins RB; Castro IA; Pontelli MC; de Barros FC; do Amaral NB; Giannini MC; Bonjorno LP; Lopes MIF; Santana RC; Vilar FC; Auxiliadora-Martins M; Luppino-Assad R; de Almeida SCL; de Oliveira FR; Batah SS; Siyuan L; Benatti MN; Cunha TM; Alves-Filho JC; Cunha FQ; Cunha LD; Frantz FG; Kohlsdorf T; Fabro AT; Arruda E; de Oliveira RDR; Louzada-Junior P; Zamboni DS
    J Exp Med; 2021 Mar; 218(3):. PubMed ID: 33231615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The purinergic 2X7 receptor participates in renal inflammation and injury induced by high-fat diet: possible role of NLRP3 inflammasome activation.
    Solini A; Menini S; Rossi C; Ricci C; Santini E; Blasetti Fantauzzi C; Iacobini C; Pugliese G
    J Pathol; 2013 Nov; 231(3):342-53. PubMed ID: 23843215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammasomes and IL-1 family cytokines in SARS-CoV-2 infection: from prognostic marker to therapeutic agent.
    Declercq J; De Leeuw E; Lambrecht BN
    Cytokine; 2022 Sep; 157():155934. PubMed ID: 35709568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paxillin mediates ATP-induced activation of P2X7 receptor and NLRP3 inflammasome.
    Wang W; Hu D; Feng Y; Wu C; Song Y; Liu W; Li A; Wang Y; Chen K; Tian M; Xiao F; Zhang Q; Chen W; Pan P; Wan P; Liu Y; Lan H; Wu K; Wu J
    BMC Biol; 2020 Nov; 18(1):182. PubMed ID: 33243234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.